AAM
WST icon

Azzad Asset Management’s West Pharmaceutical WST Stock Holding History

Azzad Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$753K Sell
2,099
-7,446
-78% -$2.28M 0.07% 273
2026
Q1 		$2.39M Sell
9,545
-280
-3% -$69.7K 0.24% 133
2025
Q4 		$2.7M Sell
9,825
-621
-6% -$170K 0.27% 129
2025
Q3 		$2.74M Sell
10,446
-133
-1% -$32.3K 0.27% 121
2025
Q2 		$2.31M Buy
10,579
+274
+3% +$58.6K 0.25% 158
2025
Q1 		$2.31M Buy
+10,305
New +$2.84M 0.27% 146
2024
Q4 		– Sell
-10,159
Closed -$3.05M – 309
2024
Q3 		$3.05M Buy
10,159
+1,289
+15% +$395K 0.34% 100
2024
Q2 		$2.92M Sell
8,870
-4,450
-33% -$1.57M 0.34% 97
2024
Q1 		$5.27M Buy
13,320
+993
+8% +$367K 0.61% 35
2023
Q4 		$4.34M Sell
12,327
-252
-2% -$89.2K 0.55% 39
2023
Q3 		$4.72M Sell
12,579
-80
-0.6% -$30.9K 0.67% 26
2023
Q2 		$4.84M Sell
12,659
-145
-1% -$51.8K 0.65% 27
2023
Q1 		$4.44M Sell
12,804
-32
-0.2% -$9.35K 0.63% 33
2022
Q4 		$3.02M Buy
12,836
+4,796
+60% +$1.14M 0.48% 59
2022
Q3 		$1.98M Buy
8,040
+113
+1% +$34.4K 0.2% 169
2022
Q2 		$2.4M Sell
7,927
-40
-0.5% -$13K 0.24% 141
2022
Q1 		$3.27M Buy
7,967
+469
+6% +$184K 0.47% 58
2021
Q4 		$3.52M Buy
7,498
+259
+4% +$111K 0.47% 57
2021
Q3 		$3.07M Sell
7,239
-60
-0.8% -$25.3K 0.45% 61
2021
Q2 		$2.62M Sell
7,299
-601
-8% -$199K 0.39% 80
2021
Q1 		$2.23M Buy
+7,900
New +$2.26M 0.37% 99
2016
Q4 		– Sell
-4,630
Closed -$345K – 241
2016
Q3 		$345K Sell
4,630
-2,834
-38% -$225K 0.14% 211
2016
Q2 		$566K Sell
7,464
-825
-10% -$60K 0.24% 153
2016
Q1 		$575K Buy
8,289
+190
+2% +$11.4K 0.25% 154
2015
Q4 		$488K Buy
8,099
+88
+1% +$5.29K 0.23% 158
2015
Q3 		$434K Buy
8,011
+267
+3% +$15.6K 0.23% 159
2015
Q2 		$450K Sell
7,744
-35
-0.4% -$1.95K 0.23% 172
2015
Q1 		$468K Buy
7,779
+792
+11% +$42.2K 0.23% 173
2014
Q4 		$372K Buy
6,987
+328
+5% +$16.4K 0.2% 204
2014
Q3 		$298K Sell
6,659
-341
-5% -$14.5K 0.17% 236
2014
Q2 		$295K Buy
7,000
+141
+2% +$6.04K 0.18% 223
2014
Q1 		$302K Buy
6,859
+409
+6% +$19.3K 0.2% 214
2013
Q4 		$316K Buy
6,450
+244
+4% +$11.4K 0.23% 180
2013
Q3 		$255K Sell
6,206
-6,206
-50% -$237K 0.21% 191
2013
Q2 		$255K Buy
+12,412
New +$408K 0.22% 189

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Azzad Asset Management's WST Position: Q2 2026 in Review

Azzad Asset Management reduced its West Pharmaceutical (WST) stake by 78% in Q2 2026, selling an estimated $2.28M and leaving 2,099 shares worth $753K. The position accounts for 0.07% of the portfolio, ranked #273.

Azzad Asset Management first reported a position in WST in Q2 2013 and has held it in 35 quarters since. The position peaked at $5.27M in Q1 2024. 305 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Azzad Asset Management held 2,099 shares of West Pharmaceutical worth $753K as of Q2 2026.
  • Azzad Asset Management sold 7,446 West Pharmaceutical shares in Q2 2026, an estimated $2.28M.
  • West Pharmaceutical made up 0.07% of Azzad Asset Management's portfolio in Q2 2026, its #273 holding.
  • Azzad Asset Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 35 quarters since.
  • Azzad Asset Management's West Pharmaceutical position peaked at $5.27M in Q1 2024.
  • 305 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.